Skip to main content

CME Group Inc.

corporate_fare Company Profile

CME Group Inc.

CME·NASDAQ·Crypto Assets·CIK 0001156375

CME Group enables clients to trade futures, options, cash, and over-the-counter (OTC) products, optimize portfolios, and analyze data. The company provides primary price discovery and referential pricing information through its market data in various formats, including real-time, historical, and derived data for customers in both listed and cash products. CME Group also offers industry-leading research and analytics tools and operates one of the world's leading central counterparty clearing providers. CME Group exchanges offer a wide range of global benchmark products across interest rates, equity indexes, foreign exchange (FX), and agricultural, energy, and metals commodities. The company also offers cash and repo fixed income trading via BrokerTec, and spot and OTC FX trading via EBS. Its derivatives exchanges (CME, CBOT, NYMEX, and COMEX) provide products that serve as risk management tools for clients globally. These products facilitate hedging, speculation, and asset allocation related to risks associated with interest rate sensitive instruments, equity ownership, cryptocurrency ownership, changes in foreign currency value, and changes in agricultural, energy, and metal commodity prices. Key products include Interest Rates (SOFR, U.S. Treasury, and Federal Funds) and Equity Indices (E-mini S&P 500, E-mini Nasdaq 100, and E-mini Russell 2000).

CME Group Inc. (NASDAQ:CME) is a publicly traded company in the Crypto Assets sector. Wiseek has independently scored 56 items for CME at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • CME Group Amends Credit Facility to $7B, Option to $10B, Enhancing Liquidity
  • CME Group Amends $7 Billion Credit Facility, Adds Option for $3 Billion Increase
  • CME Lowers Gold, Silver Futures Margins by Up to 3%
  • CME Group Reports Record Q1 Revenue, Net Income, and EPS Driven by Strong Trading Volumes
  • SEC, CFTC Approve DTCC-CME Cross-Margin Expansion, Boosting Institutional Capital Efficiency

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$6.52B
Net Income
$4.07B
Diluted EPS
$11.16
Op. Cash Flow
$4.28B
Free Cash Flow
$4.19B
Operating Income
$4.23B
Cash & Equivalents
$4.42B
Total Debt
$0
Debt / Equity
0.00×
Net Margin
62.5%
Shares Outstanding
359.65M sh
Source: 10-K · filed 2026-02-26 · accession 0001156375-26-000009
$304.11 +0.32% today
52-week range · as of 2026-10-23 $218.31 – $329.16
Market cap
$108.5B
Volume
2M (1.0× avg)
3-mo avg 2M
Live data · 2026-11-01 09:49 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CME - Filings & News (Page 3)

CME
Apr 27, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $281.94
Real-time Price: $304.11 info
Change: +$22.17 (+8%) info
Market Cap: $108.504B info
CME
Apr 27, 2026, 4:38 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $282.49
Real-time Price: $304.11 info
Change: +$21.62 (+8%) info
Market Cap: $108.504B info
CME
Apr 23, 2026, 9:26 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $285.10
Real-time Price: $304.11 info
Change: +$19.01 (+7%) info
Market Cap: $108.504B info
CME
Apr 22, 2026, 7:13 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $280.00
Real-time Price: $304.11 info
Change: +$24.11 (+9%) info
Market Cap: $108.504B info
CME
Apr 16, 2026, 8:51 AM EDT
Source: Finance Magnates
Importance Score:
7
Price at Filing: $297.32
Real-time Price: $304.11 info
Change: +$6.79 (+2%) info
Market Cap: $108.504B info
CME
Apr 07, 2026, 8:41 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $308.57
Real-time Price: $304.11 info
Change: -$4.46 (-1%) info
Market Cap: $108.504B info
CME
Apr 02, 2026, 8:16 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $296.95
Real-time Price: $304.11 info
Change: +$7.16 (+2%) info
Market Cap: $108.504B info
CME
Mar 12, 2026, 4:10 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $311.19
Real-time Price: $304.11 info
Change: -$7.08 (-2%) info
Market Cap: $108.504B info
CME
Mar 10, 2026, 12:33 PM EDT
Source: Finance Magnates
Importance Score:
7
Price at Filing: $306.48
Real-time Price: $304.11 info
Change: -$2.37 (-0.77%) info
Market Cap: $108.504B info
CME
Mar 08, 2026, 9:10 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $317.10
Real-time Price: $304.11 info
Change: -$12.99 (-4%) info
Market Cap: $108.504B info
CME
Mar 05, 2026, 4:21 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $316.89
Real-time Price: $304.11 info
Change: -$12.78 (-4%) info
Market Cap: $108.504B info
CME
Mar 03, 2026, 3:04 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $325.97
Real-time Price: $304.11 info
Change: -$21.86 (-7%) info
Market Cap: $108.504B info
CME
Mar 03, 2026, 7:32 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $327.10
Real-time Price: $304.11 info
Change: -$22.99 (-7%) info
Market Cap: $108.504B info
CME
Feb 27, 2026, 3:03 PM EST
Source: Unknown
Importance Score:
8
Price at Filing: $319.38
Real-time Price: $304.11 info
Change: -$15.27 (-5%) info
Market Cap: $108.504B info
CME
Feb 26, 2026, 5:30 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $315.69
Real-time Price: $304.11 info
Change: -$11.58 (-4%) info
Market Cap: $108.504B info
CME
Feb 04, 2026, 7:06 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $293.09
Real-time Price: $304.11 info
Change: +$11.02 (+4%) info
Market Cap: $108.504B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets